(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)

C132H157N31O46S10+2 — CID 172932353

About (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)

(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide) (PubChem CID 172932353) has the molecular formula C132H157N31O46S10+2 and a molecular weight of 3234.55 g/mol. Its IUPAC name is (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide).

Molecular Properties

• Compound Name: (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)
• PubChem CID: 172932353
• Molecular Formula: C132H157N31O46S10+2
• Molecular Weight: 3234.55 g/mol
• Exact Mass: 3231.81
• IUPAC Name: (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)
• SMILES: CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@@H]3C)c3csc(N)n3)cc2)c[n+]1C.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@@H]3C)c3csc(N)n3)cc2)cn1.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@H]3C)c3csc(N)n3)cc2)c[n+]1C.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@H]3C)c3csc(N)n3)cc2)cn1.CCCCn1cnc(-c2ccc(OC[C@H](O/N=C(\C(=O)N[C@@H]3C(=O)N(OS(=O)(=O)O)C3(C)C)c3csc(N)n3)C(=O)O)cc2)c1.O=C=O.O=C=O.O=C=O.O=C=O
• InChI: InChI=1S/C26H31N7O10S2.2C26H32N6O7S2.2C25H30N6O7S2.4CO2/c1-4-5-10-32-11-17(28-14-32)15-6-8-16(9-7-15)41-12-19(24(36)37)42-31-20(18-13-44-25(27)29-18)22(34)30-21-23(35)33(26(21,2)3)43-45(38,39)40;2*1-4-5-10-31-15-19(14-30(31)3)18-6-8-20(9-7-18)38-11-12-39-29-24(22-16-40-26(27)28-22)23(33)13-21-17(2)32(25(21)34)41(35,36)37;2*1-3-4-9-30-14-18(13-27-30)17-5-7-19(8-6-17)37-10-11-38-29-23(21-15-39-25(26)28-21)22(32)12-20-16(2)31(24(20)33)40(34,35)36;4*2-1-3/h6-9,11,13-14,19,21H,4-5,10,12H2,1-3H3,(H2,27,29)(H,30,34)(H,36,37)(H,38,39,40);2*6-9,14-17,21H,4-5,10-13H2,1-3H3,(H2-,27,28,35,36,37);2*5-8,13-16,20H,3-4,9-12H2,1-2H3,(H2,26,28)(H,34,35,36);;;;/p+2/b31-20-;2*29-24-;2*29-23-;;;;/t19-,21+;17-,21+;17-,21-;16-,20+;16-,20-;;;;/m01010..../s1
• InChIKey: JRPPGQMXMARWCS-YVNDGKIUSA-P
• XLogP: 9.20
• TPSA: 1073.60 Ų
• H-Bond Donors: 12
• H-Bond Acceptors: 68
• Rotatable Bonds: 71
• Heavy Atoms: 219
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3234.55
LogP ≤ 5	9.20
H-Bond Donors ≤ 5	12
H-Bond Acceptors ≤ 10	68

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)?

The IUPAC name of (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide) (CID 172932353) is (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide).

What is the SMILES notation for (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)?

The canonical SMILES for (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide) is CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@@H]3C)c3csc(N)n3)cc2)c[n+]1C.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@@H]3C)c3csc(N)n3)cc2)cn1.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@H]3C)c3csc(N)n3)cc2)c[n+]1C.CCCCn1cc(-c2ccc(OCCO/N=C(\C(=O)C[C@@H]3C(=O)N(S(=O)(=O)O)[C@H]3C)c3csc(N)n3)cc2)cn1.CCCCn1cnc(-c2ccc(OC[C@H](O/N=C(\C(=O)N[C@@H]3C(=O)N(OS(=O)(=O)O)C3(C)C)c3csc(N)n3)C(=O)O)cc2)c1.O=C=O.O=C=O.O=C=O.O=C=O.

What is the InChIKey of (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)?

The InChIKey is JRPPGQMXMARWCS-YVNDGKIUSA-P. The full InChI is InChI=1S/C26H31N7O10S2.2C26H32N6O7S2.2C25H30N6O7S2.4CO2/c1-4-5-10-32-11-17(28-14-32)15-6-8-16(9-7-15)41-12-19(24(36)37)42-31-20(18-13-44-25(27)29-18)22(34)30-21-23(35)33(26(21,2)3)43-45(38,39)40;2*1-4-5-10-31-15-19(14-30(31)3)18-6-8-20(9-7-18)38-11-12-39-29-24(22-16-40-26(27)28-22)23(33)13-21-17(2)32(25(21)34)41(35,36)37;2*1-3-4-9-30-14-18(13-27-30)17-5-7-19(8-6-17)37-10-11-38-29-23(21-15-39-25(26)28-21)22(32)12-20-16(2)31(24(20)33)40(34,35)36;4*2-1-3/h6-9,11,13-14,19,21H,4-5,10,12H2,1-3H3,(H2,27,29)(H,30,34)(H,36,37)(H,38,39,40);2*6-9,14-17,21H,4-5,10-13H2,1-3H3,(H2-,27,28,35,36,37);2*5-8,13-16,20H,3-4,9-12H2,1-2H3,(H2,26,28)(H,34,35,36);;;;/p+2/b31-20-;2*29-24-;2*29-23-;;;;/t19-,21+;17-,21+;17-,21-;16-,20+;16-,20-;;;;/m01010..../s1.

What are the key properties of (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide)?

(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide) has a molecular weight of 3234.55 g/mol, XLogP of 9.20, 71 rotatable bonds, 12 hydrogen bond donors, and 68 hydrogen bond acceptors.

Where does this data come from?

All data for (2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butyl-2-methylpyrazol-2-ium-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2R,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S,3S)-3-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-[2-[4-(1-butylpyrazol-4-yl)phenoxy]ethoxyimino]-2-oxopropyl]-2-methyl-4-oxoazetidine-1-sulfonic acid;(2S)-2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2,2-dimethyl-4-oxo-1-sulfooxyazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-(1-butylimidazol-4-yl)phenoxy]propanoic acid;tetrakis(carbon dioxide) is sourced from PubChem (CID 172932353), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).